| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |